VREX
Neutral signal
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Financial indicators Unavailable or mixed. Current ratio 3.43 · operating margin -3.3% — readings disagree
- Narrative Unavailable or mixed. Stored narrative reading is in the neutral band
- Timing Unavailable or mixed. No stored price series
VENTE TOTALE: 8 121 titres (~150 076,08 $ US)
- Insiders
- Kunkel Jay K.
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
$150,076
Avg sell (VWAP, 90d window) $18.46 vs last close —
- Last activity
- 2026-09-14
- Last synced
-
2026-09-20 09:54:07
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-09-14 | Kunkel Jay K. | Sell | 8,121 | $18.48 | $150,076 | Form 4 |
| 2026-09-11 | Maheshwari Shubham | Sell | 130,000 | $18.46 | $2,400,060 | Form 4 |
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
Market snapshot
Signal
Neutral signalScored 2026-09-17
VREX presents a mixed profile: the confirmed M&A rumor (Teledyne acquisition) with BlackRock's $40.6M stake provides a meaningful event-driven catalyst, but the underlying fundamentals are severely impaired with…
The first sentence of the analysis written for VREX on 2026-09-17 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-10-03 | 2024-09-27 | 2023-09-29 | 2022-09-30 | 2021-10-01 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 34.4% | 31.7% | 32.5% | 33.0% | 33.2% | |
| Ebit Margin | -2.8% | 3.9% | 6.9% | 9.4% | 8.2% | |
| Ebitda Margin | 0.4% | 7.8% | 10.6% | 13.3% | 12.8% | |
| Operating Profit Margin | -3.3% | 4.0% | 8.6% | 10.3% | 9.1% | |
| Pretax Profit Margin | -7.0% | 0.6% | 3.5% | 5.2% | 3.5% | |
| Continuous Operations Profit Margin | -8.3% | -5.8% | 5.4% | 3.6% | 2.2% | |
| Net Profit Margin | -8.3% | -5.9% | 5.3% | 3.5% | 2.1% | |
| Bottom Line Profit Margin | -8.3% | -5.9% | 5.3% | 3.5% | 2.1% | |
| Current Ratio | 3.428 | 3.318 | 4.044 | 3.523 | 3.327 | |
| Quick Ratio | 1.829 | 1.966 | 2.339 | 1.772 | 1.977 | |
| Solvency Ratio | -0.069 | -0.025 | 0.121 | 0.100 | 0.084 | |
| Cash Ratio | 0.775 | 0.861 | 0.937 | 0.516 | 0.868 | |
| Price To Earnings Ratio | -7.024 | -10.188 | 15.658 | 27.816 | 64.955 | |
| Price To Earnings Growth Ratio | -0.155 | 0.052 | 0.270 | 0.382 | -0.501 | |
| Forward Price To Earnings Growth Ratio | -0.155 | 0.052 | 0.270 | 0.382 | -0.501 | |
| Price To Earnings Diluted Ratio | -7.024 | -10.188 | 19.573 | 28.959 | 66.465 | |
| Price To Earnings Diluted Growth Ratio | -0.155 | 0.046 | 0.621 | 0.415 | -0.516 | |
| Price To Book Ratio | 1.046 | 0.909 | 1.334 | 1.577 | 2.324 | |
| Price To Sales Ratio | 0.585 | 0.600 | 0.848 | 0.979 | 1.373 | |
| Price To Free Cash Flow Ratio | 26.293 | 23.840 | 8.634 | -191.221 | 14.493 | |
| Price To Operating Cash Flow Ratio | 11.854 | 10.282 | 6.986 | 49.785 | 12.130 | |
| Debt To Assets Ratio | 0.363 | 0.387 | 0.376 | 0.368 | 0.400 | |
| Debt To Equity Ratio | 0.850 | 0.879 | 0.828 | 0.818 | 0.951 | |
| Debt To Capital Ratio | 0.460 | 0.468 | 0.453 | 0.450 | 0.487 | |
| Long Term Debt To Capital Ratio | 0.436 | 0.426 | 0.437 | 0.436 | 0.472 | |
| Financial Leverage Ratio | 2.343 | 2.274 | 2.201 | 2.220 | 2.374 | |
| Working Capital Turnover Ratio | 1.859 | 1.708 | 1.917 | 2.085 | 2.185 | |
| Operating Cash Flow Ratio | 0.223 | 0.241 | 0.666 | 0.098 | 0.556 | |
| Operating Cash Flow Sales Ratio | 0.049 | 0.058 | 0.121 | 0.020 | 0.113 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.451 | 0.431 | 0.809 | -0.260 | 0.837 | |
| Debt Service Coverage Ratio | -0.172 | 0.138 | 3.207 | 2.339 | 2.030 | |
| Interest Coverage Ratio | -0.783 | 1.032 | 2.631 | 2.151 | 1.707 | |
| Short Term Operating Cash Flow Coverage Ratio | 6.619 | 1.022 | 20.074 | 8.048 | 33.071 | |
| Operating Cash Flow Coverage Ratio | 0.104 | 0.101 | 0.231 | 0.039 | 0.202 | |
| Capital Expenditure Coverage Ratio | 1.821 | 1.758 | 5.237 | 0.793 | 6.132 | |
| Dividend Paid And Capex Coverage Ratio | 1.821 | 1.758 | 5.237 | 0.793 | 6.132 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | 214.633 | 12.528 | 11.346 | 10.379 | 13.761 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 34.4% | ▲2.7% | ▲1.5% |
| Ebit Margin | -2.8% | ▼-6.7% | ▼-7.9% |
| Ebitda Margin | 0.4% | ▼-7.3% | ▼-8.6% |
| Operating Profit Margin | -3.3% | ▼-7.2% | ▼-9.0% |
| Pretax Profit Margin | -7.0% | ▼-7.6% | ▼-8.2% |
| Continuous Operations Profit Margin | -8.3% | ▼-2.5% | ▼-7.7% |
| Net Profit Margin | -8.3% | ▼-2.4% | ▼-7.7% |
| Bottom Line Profit Margin | -8.3% | ▼-2.4% | ▼-7.7% |
| Current Ratio | 3.428 | ▲0.111 | ▼-0.100 |
| Quick Ratio | 1.829 | ▼-0.137 | ▼-0.147 |
| Solvency Ratio | -0.069 | ▼-0.045 | ▼-0.112 |
| Cash Ratio | 0.775 | ▼-0.087 | ▼-0.017 |
| Price To Earnings Ratio | -7.024 | ▲3.164 | ▼-25.267 |
| Price To Earnings Growth Ratio | -0.155 | ▼-0.207 | ▼-0.165 |
| Forward Price To Earnings Growth Ratio | -0.155 | ▼-0.207 | ▼-0.165 |
| Price To Earnings Diluted Ratio | -7.024 | ▲3.164 | ▼-26.581 |
| Price To Earnings Diluted Growth Ratio | -0.155 | ▼-0.201 | ▼-0.237 |
| Price To Book Ratio | 1.046 | ▲0.137 | ▼-0.392 |
| Price To Sales Ratio | 0.585 | ▼-0.014 | ▼-0.292 |
| Price To Free Cash Flow Ratio | 26.293 | ▲2.453 | ▲49.886 |
| Price To Operating Cash Flow Ratio | 11.854 | ▲1.572 | ▼-6.353 |
| Debt To Assets Ratio | 0.363 | ▼-0.024 | ▼-0.016 |
| Debt To Equity Ratio | 0.850 | ▼-0.029 | ▼-0.015 |
| Debt To Capital Ratio | 0.460 | ▼-0.008 | ▼-0.004 |
| Long Term Debt To Capital Ratio | 0.436 | ▲0.011 | ▼-0.005 |
| Financial Leverage Ratio | 2.343 | ▲0.069 | ▲0.060 |
| Working Capital Turnover Ratio | 1.859 | ▲0.151 | ▼-0.091 |
| Operating Cash Flow Ratio | 0.223 | ▼-0.019 | ▼-0.134 |
| Operating Cash Flow Sales Ratio | 0.049 | ▼-0.009 | ▼-0.023 |
| Free Cash Flow Operating Cash Flow Ratio | 0.451 | ▲0.019 | ▼-0.003 |
| Debt Service Coverage Ratio | -0.172 | ▼-0.310 | ▼-1.681 |
| Interest Coverage Ratio | -0.783 | ▼-1.815 | ▼-2.131 |
| Short Term Operating Cash Flow Coverage Ratio | 6.619 | ▲5.597 | ▼-7.148 |
| Operating Cash Flow Coverage Ratio | 0.104 | ▲0.003 | ▼-0.031 |
| Capital Expenditure Coverage Ratio | 1.821 | ▲0.063 | ▼-1.327 |
| Dividend Paid And Capex Coverage Ratio | 1.821 | ▲0.063 | ▼-1.327 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | 214.633 | ▲202.105 | ▲162.104 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $494.3M | $486.3M | $757.2M | $841.4M | $1.12B | |
| Enterprise value | $751.2M | $788.0M | $1.07B | $1.19B | $1.44B | |
| EV / Sales | 0.89x | 0.97x | 1.20x | 1.38x | 1.76x | |
| EV / Op. cash flow | 18.02x | 16.66x | 9.91x | 70.32x | 15.53x | |
| EV / Free cash flow | 39.96x | 38.63x | 12.25x | -270.08x | 18.55x | |
| EV / EBITDA | 214.63x | 12.53x | 11.35x | 10.38x | 13.76x | |
| Net debt / EBITDA | 73.40x | 4.80x | 3.35x | 3.03x | 3.01x | |
| Current ratio | 3.43x | 3.32x | 4.04x | 3.52x | 3.33x | |
| Income quality | -0.60x | -1.00x | 2.23x | 0.55x | 5.17x | |
| Graham number | — | — | $19 | $15 | $11 | |
| Graham net-net | -$5 | -$5 | -$5 | -$7 | -$7 | |
| Tax burden | 118.8% | -954.0% | 151.4% | 68.1% | 60.8% | |
| Interest burden | 249.8% | 15.7% | 50.9% | 55.0% | 42.6% | |
| Working capital | $454.6M | $454.0M | $495.5M | $436.8M | $387.6M | |
| Invested capital | $854.2M | $942.8M | $979.0M | $919.4M | $895.0M | |
| Return on assets | -6.3% | -3.9% | 3.8% | 2.6% | 1.5% | |
| Operating ROA | -2.4% | 2.6% | 6.3% | 7.6% | 6.5% | |
| Return on tangible assets | -7.9% | -5.2% | 5.0% | 3.5% | 2.2% | |
| Return on equity | -14.9% | -8.9% | 8.3% | 5.7% | 3.6% | |
| Return on invested capital | -3.0% | -28.3% | 7.1% | 6.0% | 4.7% | |
| Return on capital employed | -3.0% | 3.1% | 7.1% | 8.7% | 7.6% | |
| Earnings yield | -14.2% | -9.8% | 6.3% | 3.6% | 1.5% | |
| Free cash flow yield | 3.8% | 4.2% | 11.6% | -0.5% | 6.9% | |
| Capex / Op. cash flow | 54.9% | 56.9% | 19.1% | 126.0% | 16.3% | |
| Capex / Depreciation | 84.2% | 86.5% | 62.3% | 63.4% | 40.5% | |
| Capex / Sales | 2.7% | 3.3% | 2.3% | 2.5% | 1.8% | |
| SG&A / Sales | 15.8% | 17.0% | 14.4% | 13.8% | 15.3% | |
| R&D / Sales | 10.8% | 10.7% | 9.5% | 9.0% | 8.8% | |
| Stock comp / Sales | 1.8% | 1.9% | 1.5% | 1.6% | 1.7% | |
| Intangibles / Total assets | 19.2% | 25.2% | 24.9% | 26.9% | 29.9% | |
| Days sales outstanding | 68d | 71d | 67d | 74d | 69d | |
| Days payables outstanding | 46d | 39d | 39d | 50d | 39d | |
| Operating cycle | 265d | 245d | 235d | 266d | 219d | |
| Cash conversion cycle | 219d | 206d | 196d | 216d | 180d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▲+1.6%EV / Sales ▼-8.5%EV / EBITDA ▲+1613.2%EV / Op. cash flow ▲+1.354Earnings yield ▼-0.044
Profitability
Return on equity ▼-0.060Return on assets ▼-0.024Return on invested capital ▲+0.253Return on capital employed ▼-0.062Operating ROA ▼-0.050Income quality ▲+0.406Tax burden ▲+10.727
Efficiency
Days sales outstanding ▼-2.953Days payables outstanding ▲+7.114Operating cycle ▲+19.839Cash conversion cycle ▲+12.725Capex / Sales ▼-0.006R&D / Sales ▲+0.001
Balance-sheet strength
Current ratio ▲+0.111Net debt / EBITDA ▲+68.603Working capital ▲+600000.000Invested capital ▼-88600000.000Intangibles / Total assets ▼-0.061
Change over 5 years
Valuation
Market cap ▼-56.0%EV / Sales ▼-49.4%EV / EBITDA ▲+1459.8%EV / Op. cash flow ▲+2.486Earnings yield ▼-0.158
Profitability
Return on equity ▼-0.185Return on assets ▼-0.079Return on invested capital ▼-0.077Return on capital employed ▼-0.106Operating ROA ▼-0.089Income quality ▼-5.770Tax burden ▲+0.579
Efficiency
Days sales outstanding ▼-1.266Days payables outstanding ▲+6.780Operating cycle ▲+45.843Cash conversion cycle ▲+39.062Capex / Sales ▲+0.009R&D / Sales ▲+0.020
Balance-sheet strength
Current ratio ▲+0.102Net debt / EBITDA ▲+70.388Working capital ▲+67000000.000Invested capital ▼-40800000.000Intangibles / Total assets ▼-0.107
Employee count
Peer market caps
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Recent news
- 2026-09-12 VREX Stock Alert: Halper Sadeh LLC is Investigating Whether Varex Imaging Corporation is Obtaining a Fair Price for its Shareholders Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Varex Imaging Corporation (NASDAQ: VREX) to Teledyne Technologies Incorporated for $
- 2026-09-12 VREX Stock Alert: Halper Sadeh LLC is Investigating Whether Varex Imaging Corporation is Obtaining a Fair Price for its Shareholders NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Varex Imaging Corporation (NASDAQ: VREX) to Teledyne Technologies Incorporated for $18.90 per share in cash.Halper Sadeh encourages Varex shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.The investigation concerns whether Varex and its board of di.
- 2026-09-02 BlackRock Inc. Makes New $40.62 Million Investment in Varex Imaging $VREX BlackRock Inc. bought a new position in Varex Imaging (NASDAQ: VREX) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 3,894,891 shares of the company''s stock, valued at approximately $40,624,000. BlackRock Inc. owned about 9.25% of Varex Imaging at
- 2026-08-28 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Varex Imaging Corporation (Nasdaq – VREX), Synlogic, Inc. (OTC – SYBX), Bowman Consulting Group Ltd. (Nasdaq – BWMN), Nathan''s Famous, Inc. (Nasdaq – NATH) BALA CYNWYD, Pa., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
- 2026-08-24 Should Value Investors Buy VAREX IMAGING (VREX) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 2026-08-23 $HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the Merger - CHMI, VREX, HHS and ARX $HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the Merger - CHMI, VREX, HHS and ARX PR Newswire
- 2026-08-12 Are SUNS, VREX, CHMI, FBRX Obtaining Fair Deals for their Shareholders? Are SUNS, VREX, CHMI, FBRX Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Aug. 12, 2026
- 2026-08-12 Are SUNS, VREX, CHMI, FBRX Obtaining Fair Deals for their Shareholders? /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
- 2026-08-11 Varex Imaging Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Varex Imaging Corporation - VREX Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of [url="]Kahn Swick and Foti[/url], LLC (âKSFâ) are investigating the propos
- 2026-08-11 Varex Imaging Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Varex Imaging Corporation - VREX NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Varex Imaging Corporation (NasdaqGS: VREX) to Teledyne Technologies Incorporated (NYSE: TDY). Under the terms of the proposed transaction, shareholders of Varex will receive $18.90 in cash for each share of Varex that they own. KSF is seeking to determine whether this consideration and the proc.